[Asia Economy Reporter Minwoo Lee] Precision Bio announced on the 17th that it has signed a supply contract worth 9.3 billion KRW for diagnostic blood testing devices with its largest shareholder, i-SENS. This amount corresponds to 107.4% of Precision Bio's consolidated sales as of the end of last year.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing